|
HS Code |
804208 |
| Chemical Name | 16-Dehydropregnenolone |
| Molecular Formula | C21H30O2 |
| Molecular Weight | 314.46 g/mol |
| Synonyms | 16-DHP, 3β-hydroxyandrost-5,16-dien-20-one |
| Cas Number | 517-98-4 |
| Appearance | White to off-white crystalline powder |
| Pubchem Cid | 91453 |
| Melting Point | 205-209°C |
| Solubility | Slightly soluble in water, soluble in ethanol and chloroform |
| Storage Conditions | Store at 2-8°C, protect from light |
As an accredited 16-Dehydropregnenolone factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass vial containing 1 gram of 16-Dehydropregnenolone, securely sealed, labeled with CAS number, lot number, and storage instructions. |
| Shipping | 16-Dehydropregnenolone is shipped in secure, leak-proof containers, compliant with international and local chemical shipping regulations. Packaging ensures product stability and safety during transit. The shipment includes appropriate labeling, documentation, and, if required, temperature control. Delivery is arranged via certified carriers with tracking and customer support available throughout the process. |
| Storage | 16-Dehydropregnenolone should be stored in a tightly sealed container, protected from light, moisture, and air. Keep it in a cool, dry place, ideally at 2-8°C (refrigerator), unless otherwise specified by the manufacturer. Ensure it is kept away from incompatible substances, and only handled in well-ventilated areas with appropriate personal protective equipment. |
Applications of 16-Dehydropregnenolone in Industrial ManufacturingAs an established producer of 16-Dehydropregnenolone, we supply this advanced steroidal intermediate directly to pharmaceutical and fine chemical manufacturers. Below, we outline the principal industrial scenarios where this material integrates into regulated downstream production, emphasizing compliant practices, detailed formulation guidance, and the nature of finished goods. 1. Steroidal API Intermediates for Corticosteroid Synthesis16-Dehydropregnenolone is a critical intermediate in the multi-step synthesis of corticosteroids such as triamcinolone and its derivatives. Our material enters industrial synthesis chains where structural selectivity, steric purity, and traceability are paramount for active pharmaceutical ingredient (API) pre-cursors. Pharmaceutical plants typically deploy this raw material in enclosed glass-lined reactors during targeted transformations, producing steroids with anti-inflammatory functions. Compliance with trace impurity levels and validated conversion yields governs the selection and use of this intermediate. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Progestin Hormone Synthesis for Finished Dosage ProductionDownstream progestin active ingredient manufacturers employ 16-Dehydropregnenolone in process routes to synthesize gestodene, desogestrel, and other steroid hormones. Strict process controls demand traceability back through each synthetic node, from initial charge to the final hormone structure. GMP-level QC assays monitor conversion efficiency and impurity carry-over, with process validation required prior to commercial release of the resulting progestin APIs. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Steroidal Research Reagents for Biotechnology Process Development16-Dehydropregnenolone enters biotechnological research facilities as a specialty precursor in the development of new steroid analogs and pathway elucidation studies. Researchers demand batch-consistent, high-purity input in pathway engineering to optimize microbial or enzymatic process routes for next-generation steroidal molecules. Supply must document analytical certificates with HPLC and NMR spectra, and meet trace metal and endotoxin thresholds for cell-based assays. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Veterinary Steroid Pharmaceutical Formulation BasesVeterinary pharmaceutical formulators use 16-Dehydropregnenolone as a certified intermediate in preparing corticosteroid- and progestin-based veterinary injectables. Regulatory mandates at national levels demand traceable sourcing, homogeneity validation, and stability evidence for intermediates entering animal health production. Formulation specialists oversee blending with co-solvents or carrier compounds under ISO-class conditions to fulfill specifications for targeted release kinetics and shelf-life. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 16-Dehydropregnenolone prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Producing 16-Dehydropregnenolone requires deep familiarity with both the chemistry and the practical challenges of advanced steroid synthesis. In our manufacturing facility, years of hands-on experience with steroid intermediates have shaped a process that consistently delivers high purity and controlled specifications. Laboratories and pharmaceutical partners trust our 16-Dehydropregnenolone for its high assay, reviewable spectral profile, and lot-to-lot uniformity, and for the transparent way we document each production run. Our teams know that even minor impurities can derail a long cascade in steroid synthesis, so we take every step seriously: chromatographic monitoring, controlled temperature handling, and authenticated starting materials all build toward a product with reliable, chemistry-driven value.
What we produce reflects our commitment to detail. Our standard product specification focuses on crystalline 16-Dehydropregnenolone, refined to an assay exceeding 98%. The batch records aren’t just paperwork — they show real decisions made to optimize yields during crystallization, to select solvents that minimize unwanted side-products, and to control water content through measured drying. Specifications for melting range, specific rotation, and single-spot HPLC results aren’t just numbers. They’re checks we perform ourselves, using regularly calibrated equipment and recorded by technicians with years of in-lab experience. This direct oversight supports both research investigators experimenting with new pathways and established formulators creating semi-synthetic derivatives meant for clinical stages.
Working on a product like 16-Dehydropregnenolone, you see how its C16 double bond and backbone serve as both a structural challenge and an opportunity in synthesis planning. Compared to unmodified pregnenolone, the 16-dehydro variant avoids certain reduction steps, opening up strategies for producing specific analogues and metabolites that demand precise control at that position. Chemists appreciate that a genuine 16,17-double bond reduces unnecessary processing downstream. From the manufacturer’s point of view, this starts with sourcing quality precursors. We regularly review supplier documentation for cholesterol and pregnenolone derivatives, emphasizing traceability and eliminating sources of uncontrolled impurities. Teams on our floor don’t just follow a checklist; they know why each step matters.
Melting point, an often overlooked characteristic in the lab, becomes critical during scaling. Our operators know that product batches coming off the line must cool and crystallize in a controlled environment, or the result could be variable solvates, sticky intermediates, or micro-crystallization that complicates further processing. The 16-dehydro double bond changes the molecule’s packing and crystallization habits, so we designed jacketed crystallizers specifically for this intermediate. Maintaining batch uniformity for 16-Dehydropregnenolone is more than theory — each kilogram that leaves our plant has been monitored from synthesis to drying to final packing by chemists who care about what the compound will be used for next.
Request for 16-Dehydropregnenolone often comes from researchers scaling up side-chain cleavages, hydroxylations, or preparing advanced intermediates for corticosteroid or contraceptive development. Working as a direct producer, not a reseller, we learn about end-use challenges from the chemists themselves. We see where residual water or trace solvents interfere with enzymatic conversions. Customers share purification headaches, so we respond by reporting not just standard specs, but also details on trace residuals below 0.5%. That level of transparency means less troubleshooting and more time advancing synthetic campaigns where every intermediate and by-product has to be accounted for.
We routinely review our process in response to real feedback. For example, customers scaling toward gram or kilogram runs found that conventional drying techniques left trace water difficult to purge, especially given the molecule’s sensitivity to humidity. In response, we implemented double vacuum-drying with scheduled sampling for Karl Fischer titration, balancing throughput with complete removal of water. Chromatography of final lots routinely reports single compound peaks, as shown by area ratio from HPLC with dual-wavelength UV detection. Reproducibility isn’t a buzzword — it’s a hard requirement that guides each process review. Our process is built for change, adapting quickly when customers need minor modifications to particle size (for automated feed in their glassware or reactors) or adjusted packaging for moisture-sensitive supply chains.
Among steroid building blocks, pregnenolone is a staple. The 16-dehydro structure isn’t just a niche variation: it enables otherwise difficult syntheses and influences the profile of downstream analogues. Our chemists note that the unsaturation at 16-17 position increases substrate versatility for certain hydroxylation and functionalization steps. Unlike basic pregnenolone, which often requires protection and deprotection steps or intermediate oxidation for modification at C16, the dehydro version serves up that reactive site by design.
From a synthetic planning point of view, labs often choose 16-Dehydropregnenolone for its ability to reduce the number of processing steps – for corticosteroid and anti-inflammatory agent production, or for the synthesis of anabolic derivatives where a specific geometry is required at that segment. The chemical differences manifest as practical differences at scale. Handling requirements shift: the 16,17-unsaturation slightly changes solubility in common organic solvents. Our operators have learned these changes directly, refining solvent systems and filtration methods batch by batch. Differences in reactivity and crystal habit mean every purchase order starts with a lab review by a chemist who knows what down-the-line steps mean for the end user.
Every product batch represents weeks of work and careful planning. It starts with assessing incoming materials and solvent purity, then continues through stepwise monitoring of each reaction stage. Teams use TLC and HPLC alongside melting point and water content checks, but we go beyond basic quality checks. Routine NMR analysis confirms the double bond position isn’t compromised by isomerization or unintended side reactions. Experienced staff evaluate the spectral results, interpreting distinct peaks that signal a true 16-dehydro structure.
Beyond chemical analysis, we recognize the importance of packaging integrity. Crystalline steroids can absorb water or solvents if not properly sealed. Historically, inconsistent packaging has caused problems with steroid intermediates, which prompted our teams to upgrade to multilaminate foil-lined bags and rigid containers, including extra desiccants in each shipment. Adjustments like these reflect our experience—defects caught and fixed early, with a view to keeping sensitive compounds stable from departure to delivery. Each label, each bag seal, each batch certificate reflects the hands-on oversight that our chemists know matters when customers prepare for strict audits.
Most of our partners are highly knowledgeable chemists, pressure-tested by industry regulations, short timelines, and strict downstream testing protocols. We strive to produce materials that streamline their work. In response to requests from both research and production facilities, we adjust the grind or particle size cut as needed, always packaging under argon if requested. Years of making 16-Dehydropregnenolone taught us the kinds of challenges users face: filtration problems, unexpected color on standing, difficulties in dissolution, or static aggregation during handling. Foreseeing these, we keep each customer looped in with documentation that includes not just certificates of analysis, but real batch processing history.
Our approach is shaped by long feedback loops with end-users. Researchers synthesizing corticosteroid leads use our product because they’ve learned it saves time and reduces side reactions. Custom sterilization options can be deployed for pharma projects aiming toward preclinical or clinical submissions. While pharmaceutical regulatory hurdles are immense, our documentation and tracking follow best practices in auditability and reproducibility.
Producing a complex steroid intermediate isn’t left to automation alone. Our staff learn chemical safety, filtration troubleshooting, and proper oven temperature profiles through direct mentorship and, sometimes, hard-earned mistakes. Every stage in our 16-Dehydropregnenolone process incorporates both textbook knowledge and direct observation from hundreds of production runs. The equipment itself—Teflon-lined reactors, double-sealed centrifuges, and precision electronic balances—serves as tools our workers know inside and out. We maintain a strong internal safety culture: nobody “just makes do” because everything upstream affects everything downstream.
Unlike a bulk trader or repacker, a direct producer can adjust to customer insight. After hearing about problems with static or agglomeration in some laboratories’ handling, for instance, we experimented with different static dissipative liners and tested batches under varying humidity conditions. If a team in a research lab reports a problem with a residue, we walk through the process, identifying where packing or shipping may have caused a deviation. Solutions sometimes mean custom drying times or extra monitoring at dispatch. Our model prioritizes those kinds of adjustments because we know the consequences if something goes wrong — a full-scale project delay, wasted resources, or even a failed regulatory filing.
Over time, producing advanced intermediates like 16-Dehydropregnenolone builds more than just business relationships. As a manufacturer, we feel invested in the progress of our customers’ chemistry as much as in the product itself. Process engineers share their scale-up pains; university collaborators keep us updated as they experiment with novel syntheses. These partnerships encourage us to refine our process, test new purification options, and try out innovations in packaging and transport.
Consistency comes from standardizing equipment maintenance, staff cross-training, and renewing validation on analytical instruments annually. Our commitment to hands-on oversight and learning means that even as techniques evolve, our product matches the needs of both new and experienced users. Whether customers are performing advanced research or scaling toward full production, we provide not just a product, but a relationship grounded in shared experience and mutual respect for high-quality chemistry.
Direct conversations with users drive our improvement cycle. Each year brings changes in regulatory expectations, environmental conditions, or techniques in steroid chemistry. The main lesson: stay flexible. A decade ago, requests focused on bulk quantities with minimal documentation. Now, researchers and manufacturers need complete traceability, flexible lot sizes, and background information on both upstream raw material and our in-house processes. Our documentation includes synthesis route data, full analytical spectra, and accurate shelf-life projections based on real aging data, not just theoretical calculations.
Hand-in-hand with our quality system, we keep lines open for regular feedback: process modifications are considered case by case, so a process that worked for a kilogram batch might be revisited and adapted for a 50-gram or 10-kilogram run. Each modification includes review by both our production and analytical teams. In that way, the product continuously evolves in response to practical challenges, not just theoretical standards. Our adherence to proper Good Manufacturing Practice is not just for audits; it’s embedded in how we work, led by chemists who have passed through every role in our production hierarchy.
Manufacturing steroid intermediates has always carried environmental challenges — solvents, reagents, and waste all present obstacles to sustainability. Years of facing wastewater limits, stricter emissions controls, and rising solvent costs have pushed us to test alternatives. Our team has studied solvent recycling options, invested in distillation recovery, and implemented green chemistry approaches when possible. For 16-Dehydropregnenolone, these changes included reformulating to reduce high-boiling aromatic solvents and optimizing crystallization to maximize yield and reduce waste.
Product stewardship doesn’t end with production. Proper handling, staff safety training, and downstream use instruction are now provided as a regular part of our customer interaction. By briefing users on optimal storage and environmental controls, we contribute to the responsible use of the product in all stages of its life cycle. Over time, collective incremental changes — such as refining waste collection, upgrading ventilation, or phasing out certain packing materials — have created both environmental and cost benefits for us and our partners.
Our customers know that sourcing 16-Dehydropregnenolone from a direct manufacturer gives them more than simple supply. Every batch embodies the technical skill, real troubleshooting, and years of hard-won experience from our production chemists. Whether scaling up a pilot project or seeking analytical-grade purity for pharmaceutical use, our product is backed by practitioners who know the molecule inside and out. Our focus on direct feedback, incremental improvement, and hands-on quality control means laboratories and manufacturers can spend less time worrying about intermediate quality, and more time breaking new ground in steroid chemistry.
In an industry where failures can mean lost time, rising costs, and missed opportunities, our commitment to reliability and chemistry-driven support stands as our most important asset. The story of 16-Dehydropregnenolone isn’t just about a compound — it’s about what skilled manufacturers can achieve when they put their real experience and care into every batch, every process, and every partnership.